Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simulating fibrin clotting time.

Gerard Marx1

  • 1HAPTO Biotech Ltd., Hadassah Campus, P.O. Box 12275, 91121 Jerusalem, Israel. gmarx@hapto.co.il

Medical & Biological Engineering & Computing
|August 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The tripartite mechanism as the basis for a biochemical memory engram.

Journal of integrative neuroscience·2019
Same author

Oxytocin-Monolayer-Based Impedimetric Biosensor for Zinc and Copper Ions.

ACS omega·2018
Same author

Insoluble fibrinogen particles for harvesting and expanding attachment-dependent cells and for trapping suspended cancer cells in the presence of blood.

Biomedical materials (Bristol, England)·2015
Same author

The molecular basis of memory. Part 3: tagging with "emotive" neurotransmitters.

Frontiers in aging neuroscience·2014
Same author

The molecular basis of memory. Part 2: chemistry of the tripartite mechanism.

ACS chemical neuroscience·2013
Same author

The molecular basis of memory.

ACS chemical neuroscience·2012

Fibrinogen concentration impacts blood clotting time (CT) in a biphasic manner. Researchers identified a minimum fibrinogen level ([Fib]min) crucial for coagulation, aiding predictions in complex scenarios.

Area of Science:

  • Biochemistry
  • Hematology
  • Computational Biology

Background:

  • Blood clotting time (CT) is a critical diagnostic parameter.
  • Fibrinogen is a key protein in the coagulation cascade.
  • Understanding fibrinogen's role at varying concentrations is essential for diagnostics and therapeutics.

Purpose of the Study:

  • To investigate the relationship between fibrinogen concentration and clotting time.
  • To determine the minimal fibrinogen concentration ([Fib]min) required for coagulation.
  • To develop and validate a dynamic simulation model for blood coagulation.

Main Methods:

  • Experimental determination of CT across a wide range of fibrinogen concentrations.
  • Utilizing a dynamic simulation program (Stella) to model coagulation mechanisms.

Related Experiment Videos

  • Comparing simulation outputs with experimental data to refine the model.

    • Main Results:

    • Clotting time exhibited a biphasic response to increasing fibrinogen levels.
    • A minimal fibrinogen concentration ([Fib]min) of 0.2 ± 0.05 μM was determined.
    • The simulation successfully replicated the biphasic CT behavior and identified fibrinogen's multiple roles.

    Conclusions:

    • Fibrinogen acts as a substrate, precursor, and competitor in the coagulation process.
    • The developed simulation model accurately predicts CT, accounting for fibrinogen's complex interactions.
    • This approach can enhance CT prediction in complex biological systems like whole blood or pathological plasmas.